Completed PHASE2 INTERVENTIONAL 2-arm NCT01987609

Effects of Subcutaneous Hyaluronidase Administration on Psoriatic Plaques

Evaluation of the Effect of Subcutaneous Hyaluronidase Administration on Psoriatic Plaques

Sponsor: Tissa Hata, MD

Conditions Psoriasis

Updated 7 times since 2017 Last updated: Dec 28, 2018 Started: Jul 31, 2015 Primary completion: Mar 31, 2017 Completion: Feb 28, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Psoriasis, this trial is completed. The trial is conducted by Tissa Hata, MD and has accumulated 7 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Feb 2019 — Jan 2021 [monthly]

Completed PHASE2

Status: Recruiting → Completed
Jun 2018 — Feb 2019 [monthly]

Recruiting PHASE2

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Recruiting PHASE2
Jan 2017 — Feb 2017 [monthly]

Recruiting PHASE2

First recorded

Jul 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Tissa Hata, MD

Data source: University of California, San Diego

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• San Diego, United States